300mg Plavix was approved by CHMP
Sanofi Aventis and Bristol-Myers Squibb Company announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion recommending approval of the 300mg tablet of the antiplatelet Plavix (clopidogrel bisulfate). This positive opinion from the CHMP needs to be ratified by the European Commission [...]